Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Gastrointest Endosc Clin N Am. 2014 Jul;24(3):367-78. doi: 10.1016/j.giec.2014.03.005. Epub 2014 May 6.

Mucosal healing as a target of therapy for colonic inflammatory bowel disease and methods to score disease activity.

Author information

  • 1Gastroenterology Department, St Vincent's Hospital, 390 Victoria Street, Darlinghurst, Sydney NSW 2010, Australia.
  • 2Translational Gastroenterology Unit, John Radcliffe Hospital, Oxford OX3 9DU, UK.
  • 3Translational Gastroenterology Unit, John Radcliffe Hospital, Oxford OX3 9DU, UK. Electronic address: Simon.Travis@ndm.ox.ac.uk.

Abstract

Mucosal healing is an important therapeutic end point in clinical trials and clinical practice. There is no validated definition of mucosal healing in patients with inflammatory bowel disease, although the benefits of achieving mucosal healing include decreased need for corticosteroids, sustained clinical remission, decreased colectomy, and bowel resection. The Ulcerative Colitis Endoscopic Index of Severity is the only validated endoscopic index in ulcerative colitis. The Crohn's Disease Endoscopic Index of Severity and the Simple Endoscopic Score for Crohn's Disease are validated for Crohn disease, and the Rutgeerts Postoperative Endoscopic Index is used to predict recurrence after an ileocolic resection.

Copyright © 2014 Elsevier Inc. All rights reserved.

KEYWORDS:

Crohn's disease; Inflammatory bowel disease; Mucosal healing; Ulcerative colitis

PMID:
24975528
[PubMed - in process]
Free full text

Publication Types

Publication Types

PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for W.B. Saunders Icon for Elsevier Science
    Loading ...
    Write to the Help Desk